Lynsey Chediak is Rarebase’s head of partnerships. She was born with a rare genetic bone and joint disease called arthrogryposis. Formerly, she led the inaugural precision medicine portfolio at the World Economic Forum. She is also the Founder and CEO of a rare disease patient advocacy non-profit, working to increase patient engagement across pediatric hospitals in the USA. Prior to the Forum, she worked on health policy in the California Governor’s Office and in the United Kingdom’s Parliament. She was one of 100 entrepreneurs selected from across the USA for the prestigious Venture for America fellowship.